AOD-9604: Metabolic Peptide Research Guide

> Educational Content Only: This compound is discussed for educational purposes only and is not currently offered by our company. AOD-9604 (Advanced Obesity Drug) is a synthetic peptide fragment corresponding to amino acids 177-191 of human growth hormone (hGH). Developed by Metabolic Pharmaceuticals in Australia, this modified peptide was designed to retain the lipolytic (fat-burning) properties of growth hormone while eliminating the growth-promoting and diabetogenic effects. - Molecular Weight: 1,815 Da - Amino Acid Sequence: hGH fragment 177-191 with tyrosine substitution - Modification: C-terminal tyrosine added to enhance stability - Structure: Linear peptide fragment - Solubility: Water-soluble AOD-9604 operates through a distinct mechanism from intact growth hormone: - Beta-3 Adrenergic Receptor Interaction: May enhance beta-3 receptor sensitivity - Adipocyte Targeting: Specifically affects adipose tissue metabolism - No IGF-1 Elevation: Does not stimulate insulin-like growth factor production - No Growth Effects: Lacks the growth-promoting properties of full hGH - Fat Oxidation: Stimulates breakdown of stored triglycerides - Lipogenesis Inhibition: May reduce new fat synthesis - Metabolic Rate: Potential effects on basal metabolic rate - Glucose Neutral: Does not adversely affect blood glucose levels Unlike full growth hormone, AOD-9604: - Does not cause cellular proliferation - Does not affect blood glucose - Does not stimulate IGF-1 release - Targets adipose tissue specifically Primary research areas include: - Lipolytic mechanism studies - Obesity treatment models - Metabolic syndrome research - Adipocyte biology Emerging research has explored: - Chondrocyte regeneration - Cartilage repair mechanisms - Osteoarthritis models - Joint tissue healing Studies have investigated: - hGH fragment biology - Structure-function relationships - Receptor binding specificity - Separation of hGH activities | Research Area | Key Finding | |---------------|-------------| | Lipolysis | Stimulates fat breakdown in adipocytes | | Growth | No effect on growth or IGF-1 levels | | Glucose | Does not impair glucose tolerance | | Safety | Generally well-tolerated in studies | | Cartilage | May promote chondrocyte proliferation | AOD-9604 has an interesting research history: - Originally developed as obesity therapeutic - Advanced to Phase IIb clinical trials - Later investigated for cartilage regeneration - Received GRAS (Generally Recognized as Safe) status for food applications | Property | AOD-9604 | Full hGH | hGH 177-191 | |----------|----------|----------|-------------| | Lipolytic | Yes | Yes | Yes | | Growth Promoting | No | Yes | No | | Diabetogenic | No | Yes | No | | IGF-1 Increase | No | Yes | No | For research purposes: - Store lyophilized at -20°C - Reconstitute with bacteriostatic water - Protect from light and heat - Stable for weeks refrigerated after reconstitution - Avoid repeated freeze-thaw cycles 1. N